Trust Company of the Ozarks’s GSK GSK Stock Holding History

Trust Company of the Ozarks’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.51M	Buy	31,436 +740	+2%	+$38.5K	0.52%	41
2015 Q2	$1.6M	Buy	30,696 +1,834	+6%	+$103K	0.44%	43
2015 Q1	$1.67M	Buy	28,862 +1,470	+5%	+$84.3K	0.44%	37
2014 Q4	$1.46M	Buy	27,392 +596	+2%	+$33.3K	0.41%	46
2014 Q3	$1.54M	Buy	26,796 +19,100	+248%	+$1.17M	0.43%	39
2014 Q2	$515K	Hold	7,696	–	–	0.14%	111
2014 Q1	$514K	Buy	7,696 +317	+4%	+$21.4K	0.15%	109
2013 Q4	$493K	Hold	7,379	–	–	0.14%	109
2013 Q3	$463K	Buy	7,379 +240	+3%	+$15.4K	0.15%	107
2013 Q2	$446K	Buy	+7,139	New	+$453K	0.15%	105

Other funds holding GSK

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Trust Company of the Ozarks's GSK Position: Q3 2015 in Review

Trust Company of the Ozarks increased its GSK (GSK) stake by 2.4% in Q3 2015, buying an estimated $38.5K and bringing the position to 31,436 shares worth $1.51M. The position accounts for 0.52% of the portfolio, ranked #41.

Trust Company of the Ozarks first reported a position in GSK in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.67M in Q1 2015. 707 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

Trust Company of the Ozarks held 31,436 shares of GSK worth $1.51M as of Q3 2015.
Trust Company of the Ozarks bought 740 GSK shares in Q3 2015, an estimated $38.5K.
GSK made up 0.52% of Trust Company of the Ozarks's portfolio in Q3 2015, its #41 holding.
Trust Company of the Ozarks first reported a position in GSK in Q2 2013 and has held it in 10 quarters since.
Trust Company of the Ozarks's GSK position peaked at $1.67M in Q1 2015.
707 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Trust Company of the Ozarks's 13F filing for Q3 2015, filed 4 Nov 2015.